Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) announced updated data from its ongoing ARCT-154 booster clinical trial. The new results demonstrate a broad…
89bio (NASDAQ: ETNB) has completed enrollment in ENLIVEN, the Phase 2b trial of pegozafermin for the treatment of non-alcoholic steatohepatitis (NASH).
A 20-year-old college student earned around $110 million after selling his stake in the troubled retailer Bed Bath & Beyond Inc (NASDAQ: BBBY) following the stock's recent rally of more than 339%, according to the Financi
Big techs are among the highly-profitable companies given their strong revenue growth and cost discipline. Tech giant Apple, Inc. (NASDAQ: AAPL) led Fortune 500’s list of the most profitable U.S. corporations in 2021, with an annual profit of $94.7 billion.